Skip to main content
DD

Delphi Diagnostics Inc.

The startup specializes in diagnostic and predictive testing for breast cancer, utilizing advanced biomarker analysis to enhance treatment accuracy. This approach enables patients and healthcare providers to improve disease-free survival rates while minimizing unnecessary treatments and associated toxicity.

Houston, United States · HQ
Founded 201612300+ followers
  • Biotechnology
  • Healthcare Technology
  • Software Only
Updated 5 months ago

Funding

Raised to date

$470KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Condie Carmack

Entrepreneur

Product

Features

  • The startup specializes in diagnostic and predictive testing for breast cancer, utilizing advanced biomarker analysis to enhance treatment accuracy. This approach enables patients and healthcare providers to improve disease-free survival rates while minimizing unnecessary treatments and associated toxicity.
This profile is AI-generated and may contain inaccuracies.